Cite
HARVARD Citation
Aoki, M. et al. (2019). Hyperprogressive disease during nivolumab or irinotecan treatment in patients with advanced gastric cancer. ESMO open. 4 (3), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Aoki, M. et al. (2019). Hyperprogressive disease during nivolumab or irinotecan treatment in patients with advanced gastric cancer. ESMO open. 4 (3), p. . [Online].